Effect of Triazolam on Polysomnography in Patients with Insomnia

Zhang Mingdao,Chen Xingshi,Wang Hongxing,Lou Feiying,Wang Jijun,Liu Xiaowei,Tao Mingyi,Zhang Haiyin,Guo qi

DOI: https://doi.org/10.3969/j.issn.1672-7061.2005.01.012

2005-01-01

Abstract:Objective To research the effect of triazolam on polysomnography(PSG)in patients with insomnia, using Neurofax-1518K(Nihon Kohden)sleep instrument.Methods The PSG recorded the data of 28 patients with insomnia for 4 consecutive nights,who were given 0.5 mg triazolam before sleep during the 3rd & 4th nights.In 33 normal subjects for two baseline nights accommodation and screening were made.Results After oral administration of triazolam,the insomnia patients presented improved sleep efficiency(baseline:86.9%,1 st administration:91± 8%,2 nd administration:92±4%,F=6.143,P<0.01),reduced awakening time(baseline:39±17,1 st admin- istration:29±8,2 nd administration:23±7,F=13.211,P<0.01),reduced stage 1 time(baseline:31±18%,1 st administration:23±11%,2 nd administration:16±6%,F=9.707,P<0.01),increased stage 2(baseline:45± 17%,1st administration:59±18%,2 nd administration:60±6%,F=10.104,P<0.01),shortened sleep latency (baseline:35±18 min,1 st administration:28±17,2 nd administration:21±11 min,F=4.947,P<0.05). Conclusion Short-half-life of hyponotic triazolam can improve insomnia patients'subjective evaluation of sleep and has stone effect on PSG at night.